| NABRIVA THERAPEUTICS AG Patent applications |
| Patent application number | Title | Published |
|---|
| 20110184022 | Organic Compounds - Compounds of formula (I), which are 14-O-{[(optionally substituted hydroxy)cyclohexyl)sulfanyl]acetyl}mutilins further substituted at the cyclohexyl group by an acylated amino group, salts and solvates thereof, pharmaceutical compositions comprising such compounds and their use as a pharmaceutical, e.g. for the treatment of diseases mediated by microbes and for the treatment of inflammation where microbese are mediating said inflammation. | 07-28-2011 |
| 20100197734 | PLEUROMUTILIN DERIVATIVES AND THEIR USE AS ANTIMICROBIALS - A compound of formula (I) or of formula (II) wherein X is oxygen or sulfur, and Y is a residue of pipecolic acid or a residue of an amino acid, preferably a naturally occurring amino acid. | 08-05-2010 |
| 20100190855 | ORGANIC COMPOUNDS - A compound of formula (I) wherein Y is oxygen or sulfur, and X | 07-29-2010 |
| 20100035987 | PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES - A pleuromutilin derivative compound of general formula (I) | 02-11-2010 |
| 20090253748 | PROCESS FOR THE PREPARATION OF PLEUROMUTILINS - A process for the preparation of 14-O-[(N-(3-methyl-2-amino-butyryl-piperidinyl)sulfanyl) acetyl]mutilins of formula (I) feasible for large-scale production of high purity products, and wherein the carbon atom at the piperidine ring attached to the sulphur atom is either in the (S)-configuration or in the (R)-configuration, and a new crystalline form of 14-O-[(N-3-methyl-2-(R)-amino-butyryl-piperidine-3(S)-yl)sulfanyl)acetyl]mutilin-hydrochloride. | 10-08-2009 |
